201 related articles for article (PubMed ID: 28228639)
1. GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function.
Chen W; Shieh C; Swanger SA; Tankovic A; Au M; McGuire M; Tagliati M; Graham JM; Madan-Khetarpal S; Traynelis SF; Yuan H; Pierson TM
J Hum Genet; 2017 Jun; 62(6):589-597. PubMed ID: 28228639
[TBL] [Abstract][Full Text] [Related]
2. Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy.
Lemke JR; Geider K; Helbig KL; Heyne HO; Schütz H; Hentschel J; Courage C; Depienne C; Nava C; Heron D; Møller RS; Hjalgrim H; Lal D; Neubauer BA; Nürnberg P; Thiele H; Kurlemann G; Arnold GL; Bhambhani V; Bartholdi D; Pedurupillay CR; Misceo D; Frengen E; Strømme P; Dlugos DJ; Doherty ES; Bijlsma EK; Ruivenkamp CA; Hoffer MJ; Goldstein A; Rajan DS; Narayanan V; Ramsey K; Belnap N; Schrauwen I; Richholt R; Koeleman BP; Sá J; Mendonça C; de Kovel CG; Weckhuysen S; Hardies K; De Jonghe P; De Meirleir L; Milh M; Badens C; Lebrun M; Busa T; Francannet C; Piton A; Riesch E; Biskup S; Vogt H; Dorn T; Helbig I; Michaud JL; Laube B; Syrbe S
Neurology; 2016 Jun; 86(23):2171-8. PubMed ID: 27164704
[TBL] [Abstract][Full Text] [Related]
3. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
[TBL] [Abstract][Full Text] [Related]
4. GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms.
Ragnarsson L; Zhang Z; Das SS; Tran P; Andersson Å; des Portes V; Desmettre Altuzarra C; Remerand G; Labalme A; Chatron N; Sanlaville D; Lesca G; Anggono V; Vetter I; Keramidas A
Epilepsia; 2023 Dec; 64(12):3377-3388. PubMed ID: 37734923
[TBL] [Abstract][Full Text] [Related]
5. The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.
Hamada S; Ogawa I; Yamasaki M; Kiyama Y; Kassai H; Watabe AM; Nakao K; Aiba A; Watanabe M; Manabe T
Eur J Neurosci; 2014 Oct; 40(8):3136-46. PubMed ID: 25131300
[TBL] [Abstract][Full Text] [Related]
6. Neto1 associates with the NMDA receptor/amyloid precursor protein complex.
Cousins SL; Innocent N; Stephenson FA
J Neurochem; 2013 Sep; 126(5):554-64. PubMed ID: 23621516
[TBL] [Abstract][Full Text] [Related]
7. Abnormal circadian rhythm in patients with GRIN1-related developmental epileptic encephalopathy.
Scala M; Amadori E; Fusco L; Marchese F; Capra V; Minetti C; Vari MS; Striano P
Eur J Paediatr Neurol; 2019 Jul; 23(4):657-661. PubMed ID: 31176596
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat recombinant GluN1/GluN2A and GluN1/GluN2B NMDA receptors by ethanol at concentrations based on the US/UK drink-drive limit.
Otton HJ; Janssen A; O'Leary T; Chen PE; Wyllie DJ
Eur J Pharmacol; 2009 Jul; 614(1-3):14-21. PubMed ID: 19394328
[TBL] [Abstract][Full Text] [Related]
9. The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors.
Kolcheva M; Ladislav M; Netolicky J; Kortus S; Rehakova K; Krausova BH; Hemelikova K; Misiachna A; Kadkova A; Klima M; Chalupska D; Horak M
Neuropharmacology; 2023 Jan; 222():109297. PubMed ID: 36341805
[TBL] [Abstract][Full Text] [Related]
10. Novel homozygous missense variant of GRIN1 in two sibs with intellectual disability and autistic features without epilepsy.
Rossi M; Chatron N; Labalme A; Ville D; Carneiro M; Edery P; des Portes V; Lemke JR; Sanlaville D; Lesca G
Eur J Hum Genet; 2017 Feb; 25(3):376-380. PubMed ID: 28051072
[TBL] [Abstract][Full Text] [Related]
11. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
[TBL] [Abstract][Full Text] [Related]
12. De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.
Fry AE; Fawcett KA; Zelnik N; Yuan H; Thompson BAN; Shemer-Meiri L; Cushion TD; Mugalaasi H; Sims D; Stoodley N; Chung SK; Rees MI; Patel CV; Brueton LA; Layet V; Giuliano F; Kerr MP; Banne E; Meiner V; Lerman-Sagie T; Helbig KL; Kofman LH; Knight KM; Chen W; Kannan V; Hu C; Kusumoto H; Zhang J; Swanger SA; Shaulsky GH; Mirzaa GM; Muir AM; Mefford HC; Dobyns WB; Mackenzie AB; Mullins JGL; Lemke JR; Bahi-Buisson N; Traynelis SF; Iago HF; Pilz DT
Brain; 2018 Mar; 141(3):698-712. PubMed ID: 29365063
[TBL] [Abstract][Full Text] [Related]
13. N-terminal alternative splicing of GluN1 regulates the maturation of excitatory synapses and seizure susceptibility.
Liu H; Wang H; Peterson M; Zhang W; Hou G; Zhang ZW
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21207-21212. PubMed ID: 31570583
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and electrophysiological characterization of N-glycans on NMDA receptor subunits.
Kaniakova M; Lichnerova K; Skrenkova K; Vyklicky L; Horak M
J Neurochem; 2016 Aug; 138(4):546-56. PubMed ID: 27216994
[TBL] [Abstract][Full Text] [Related]
16. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
[TBL] [Abstract][Full Text] [Related]
17. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
18. Paradigmatic De Novo
Santos-Gómez A; Miguez-Cabello F; Juliá-Palacios N; García-Navas D; Soto-Insuga V; García-Peñas JJ; Fuentes P; Ibáñez-Micó S; Cuesta L; Cancho R; Andreo-Lillo P; Gutiérrez-Aguilar G; Alonso-Luengo O; Málaga I; Hedrera-Fernández A; García-Cazorla À; Soto D; Olivella M; Altafaj X
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884460
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
[TBL] [Abstract][Full Text] [Related]
20. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
